Finding 1096013 (2024-001)

Significant Deficiency
Requirement
C
Questioned Costs
-
Year
2024
Accepted
2025-01-17

AI Summary

  • Core Issue: The Institute drew down funds beyond the recommended three-day limit, leading to non-compliance with cash management regulations.
  • Impacted Requirements: Violated 2 CFR 215.22, which mandates minimizing the time between fund transfers and payments.
  • Recommended Follow-Up: Enhance procedures for federal fund advances and establish a cash reserve to maintain operational cash flow.

Finding Text

Section III - Federal Award Findings and Questioned Costs: 2024-001: Cash Management U.S. Department of Health and Human Services Research and Development Cluster – 93.RD Condition Funds were drawn down by the Institute in excess of the three day period recommended by its funding agency and did not minimize the time elapsing between the transfers of funds from the grantor to the issue of payment by the recipient during the year ended June 30, 2024. Criteria Cash management under 2 CFR 215.22 states that payment methods shall minimize the time elapsing between the transfers of funds from the grantor to the issue of payment by the recipient. Cause The Institute’s preparation and review procedures over the drawdown of funds were insufficient to minimize the time elapsing between the transfers of funds from the grantor to the issue of payments by the Institute. Effect The Institute was not in compliance with the cash management compliance requirements stated in 2 CFR 215.22 during the year and the Institute had an overdrawn balance of $481,959 at June 30, 2024. Recommendation The Institute should improve its procedures over advances of federal funds. Management Response Establish a reserve amount to avoid drawing down all available funds, ensuring that there is always sufficient cash flow to meet operational needs. This reserve is intended to cover unexpected expenses, emergencies, or fluctuations in cash flow.

Categories

Cash Management

Other Findings in this Audit

  • 519564 2024-001
    Significant Deficiency
  • 519565 2024-001
    Significant Deficiency
  • 519566 2024-001
    Significant Deficiency
  • 519567 2024-001
    Significant Deficiency
  • 519568 2024-001
    Significant Deficiency
  • 519569 2024-001
    Significant Deficiency
  • 519570 2024-001
    Significant Deficiency
  • 519571 2024-001
    Significant Deficiency
  • 519572 2024-001
    Significant Deficiency
  • 519573 2024-001
    Significant Deficiency
  • 519574 2024-001
    Significant Deficiency
  • 519575 2024-001
    Significant Deficiency
  • 519576 2024-001
    Significant Deficiency
  • 519577 2024-001
    Significant Deficiency
  • 519578 2024-001
    Significant Deficiency
  • 519579 2024-001
    Significant Deficiency
  • 519580 2024-001
    Significant Deficiency
  • 519581 2024-001
    Significant Deficiency
  • 1096006 2024-001
    Significant Deficiency
  • 1096007 2024-001
    Significant Deficiency
  • 1096008 2024-001
    Significant Deficiency
  • 1096009 2024-001
    Significant Deficiency
  • 1096010 2024-001
    Significant Deficiency
  • 1096011 2024-001
    Significant Deficiency
  • 1096012 2024-001
    Significant Deficiency
  • 1096014 2024-001
    Significant Deficiency
  • 1096015 2024-001
    Significant Deficiency
  • 1096016 2024-001
    Significant Deficiency
  • 1096017 2024-001
    Significant Deficiency
  • 1096018 2024-001
    Significant Deficiency
  • 1096019 2024-001
    Significant Deficiency
  • 1096020 2024-001
    Significant Deficiency
  • 1096021 2024-001
    Significant Deficiency
  • 1096022 2024-001
    Significant Deficiency
  • 1096023 2024-001
    Significant Deficiency

Programs in Audit

ALN Program Name Expenditures
93.393 Cancer Cause and Prevention Research $644,032
93.113 Environmental Health $605,823
93.853 Extramural Research Programs in the Neurosciences and Neurological Disorders $525,085
93.859 Biomedical Research and Research Training $391,138
93.310 Trans-Nih Research Support $380,260
93.866 Aging Research $262,003
93.279 Drug Abuse and Addiction Research Programs $228,625
93.855 Allergy and Infectious Diseases Research $35,026
93.172 Human Genome Research $31,643